Literature DB >> 26260244

Enhanced conversion of induced neuronal cells (iN cells) from human fibroblasts: Utility in uncovering cellular deficits in mental illness-associated chromosomal abnormalities.

Eleonora Passeri1, Ashley M Wilson1, Amedeo Primerano1, Mari A Kondo1, Srona Sengupta1, Rupali Srivastava1, Minori Koga1, Cassandra Obie2, Peter P Zandi3, Fernando S Goes1, David Valle2, Judith L Rapoport4, Akira Sawa5, Shin-ichi Kano6, Koko Ishizuka7.   

Abstract

The novel technology of induced neuronal cells (iN cells) is promising for translational neuroscience, as it allows the conversion of human fibroblasts into cells with postmitotic neuronal traits. However, a major technical barrier is the low conversion rate. To overcome this problem, we optimized the conversion media. Using our improved formulation, we studied how major mental illness-associated chromosomal abnormalities may impact the characteristics of iN cells. We demonstrated that our new iN cell culture protocol enabled us to obtain more precise measurement of neuronal cellular phenotypes than previous iN cell methods. Thus, this iN cell culture provides a platform to efficiently obtain possible cellular phenotypes caused by genetic differences, which can be more thoroughly studied in research using other human cell models such as induced pluripotent stem cells.
Copyright © 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Childhood-onset schizophrenia; Conversion rate; Copy number variations (CNVs); Fibroblasts; Process length; Schizophrenia; Translational research; iN cells

Mesh:

Substances:

Year:  2015        PMID: 26260244      PMCID: PMC4774521          DOI: 10.1016/j.neures.2015.07.011

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  24 in total

1.  The DNA sequence of human chromosome 22.

Authors:  I Dunham; N Shimizu; B A Roe; S Chissoe; A R Hunt; J E Collins; R Bruskiewich; D M Beare; M Clamp; L J Smink; R Ainscough; J P Almeida; A Babbage; C Bagguley; J Bailey; K Barlow; K N Bates; O Beasley; C P Bird; S Blakey; A M Bridgeman; D Buck; J Burgess; W D Burrill; K P O'Brien
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 2.  Epigenetic reprogramming and induced pluripotency.

Authors:  Konrad Hochedlinger; Kathrin Plath
Journal:  Development       Date:  2009-02       Impact factor: 6.868

Review 3.  Childhood-onset schizophrenia: rare but worth studying.

Authors:  R Nicolson; J L Rapoport
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

4.  Mechanisms of action of unoprostone on trabecular meshwork contractility.

Authors:  H Thieme; F Stumpff; A Ottlecz; C L Percicot; G N Lambrou; M Wiederholt
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-12       Impact factor: 4.799

5.  Cellular and molecular effects of unoprostone as a BK channel activator.

Authors:  John Cuppoletti; Danuta H Malinowska; Kirti P Tewari; Jayati Chakrabarti; Ryuji Ueno
Journal:  Biochim Biophys Acta       Date:  2007-01-03

Review 6.  Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucoma.

Authors:  S Melamed
Journal:  Drugs Exp Clin Res       Date:  2002

7.  Changes of enzymes involved in prostaglandin metabolism and prostaglandin binding proteins in rat brain during development and aging.

Authors:  R Ueno; H Osama; Y Urade; O Hayaishi
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

Review 8.  The genetics of childhood-onset schizophrenia: when madness strikes the prepubescent.

Authors:  Anjené M Addington; Judith L Rapoport
Journal:  Curr Psychiatry Rep       Date:  2009-04       Impact factor: 5.285

9.  Microduplications of 16p11.2 are associated with schizophrenia.

Authors:  Shane E McCarthy; Vladimir Makarov; George Kirov; Anjene M Addington; Jon McClellan; Seungtai Yoon; Diana O Perkins; Diane E Dickel; Mary Kusenda; Olga Krastoshevsky; Verena Krause; Ravinesh A Kumar; Detelina Grozeva; Dheeraj Malhotra; Tom Walsh; Elaine H Zackai; Paige Kaplan; Jaya Ganesh; Ian D Krantz; Nancy B Spinner; Patricia Roccanova; Abhishek Bhandari; Kevin Pavon; B Lakshmi; Anthony Leotta; Jude Kendall; Yoon-Ha Lee; Vladimir Vacic; Sydney Gary; Lilia M Iakoucheva; Timothy J Crow; Susan L Christian; Jeffrey A Lieberman; T Scott Stroup; Terho Lehtimäki; Kaija Puura; Chad Haldeman-Englert; Justin Pearl; Meredith Goodell; Virginia L Willour; Pamela Derosse; Jo Steele; Layla Kassem; Jessica Wolff; Nisha Chitkara; Francis J McMahon; Anil K Malhotra; James B Potash; Thomas G Schulze; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Ellen Leibenluft; Vlad Kustanovich; Clara M Lajonchere; James S Sutcliffe; David Skuse; Michael Gill; Louise Gallagher; Nancy R Mendell; Nick Craddock; Michael J Owen; Michael C O'Donovan; Tamim H Shaikh; Ezra Susser; Lynn E Delisi; Patrick F Sullivan; Curtis K Deutsch; Judith Rapoport; Deborah L Levy; Mary-Claire King; Jonathan Sebat
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  8 in total

1.  Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls.

Authors:  Eleonora Passeri; Lorraine Jones-Brando; Claudia Bordón; Srona Sengupta; Ashley M Wilson; Amedeo Primerano; Judith L Rapoport; Koko Ishizuka; Shin-ichi Kano; Robert H Yolken; Akira Sawa
Journal:  Microbes Infect       Date:  2015-10-09       Impact factor: 2.700

Review 2.  Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?

Authors:  Janelle Drouin-Ouellet; Karolina Pircs; Roger A Barker; Johan Jakobsson; Malin Parmar
Journal:  Front Neurosci       Date:  2017-09-28       Impact factor: 4.677

3.  Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study.

Authors:  Noriaki Sagata; Takahiro A Kato; Shin-Ichi Kano; Masahiro Ohgidani; Norihiro Shimokawa; Mina Sato-Kasai; Kohei Hayakawa; Nobuki Kuwano; Ashley M Wilson; Koko Ishizuka; Shiori Kato; Takeshi Nakahara; Makiko Nakahara-Kido; Daiki Setoyama; Yasunari Sakai; Shouichi Ohga; Masutaka Furue; Akira Sawa; Shigenobu Kanba
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

Review 4.  Use of Human Neurons Derived via Cellular Reprogramming Methods to Study Host-Parasite Interactions of Toxoplasma gondii in Neurons.

Authors:  Sandra K Halonen
Journal:  Cells       Date:  2017-09-23       Impact factor: 6.600

5.  Forskolin rapidly enhances neuron-like morphological change of directly induced-neuronal cells from neurofibromatosis type 1 patients.

Authors:  Noriaki Sagata; Shin-Ichi Kano; Masahiro Ohgidani; Shogo Inamine; Yasunari Sakai; Hiroki Kato; Keiji Masuda; Takeshi Nakahara; Makiko Nakahara-Kido; Shouichi Ohga; Masutaka Furue; Akira Sawa; Shigenobu Kanba; Takahiro A Kato
Journal:  Neuropsychopharmacol Rep       Date:  2020-10-10

Review 6.  The application of in vitro-derived human neurons in neurodegenerative disease modeling.

Authors:  Gary X D'Souza; Shannon E Rose; Allison Knupp; Daniel A Nicholson; Christopher Dirk Keene; Jessica E Young
Journal:  J Neurosci Res       Date:  2020-03-13       Impact factor: 4.164

7.  CBX2 Inhibits Neurite Development by Regulating Neuron-Specific Genes Expression.

Authors:  Xi Gu; Xuemin Wang; Dazhuang Su; Xiaohong Su; Lifang Lin; Shuji Li; Qiaoqi Wu; Shuhu Liu; Peidong Zhang; Xinhong Zhu; Xiaodan Jiang
Journal:  Front Mol Neurosci       Date:  2018-02-28       Impact factor: 5.639

Review 8.  Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence.

Authors:  Ulrich Sauerzopf; Roberto Sacco; Gaia Novarino; Marco Niello; Ana Weidenauer; Nicole Praschak-Rieder; Harald Sitte; Matthäus Willeit
Journal:  Eur J Neurosci       Date:  2016-10-19       Impact factor: 3.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.